Introduction
Blanc expanded on the work of Peters (1977) and Prizant (1984) to develop the Natural Language Acquisition (NLA) framework, outlining stages and strategies for supporting gestalt language processors (GLPs). Clinicians debate whether to program gestalts into AAC devices for GLPs who use AAC. Although widely used, these strategies lack strong empirical testing. Evidence-based practice (EBP) requires integration of clinical expertise, research evidence, and client/caregiver perspectives (ASHA, n.d.). Critics argue that GLP strategies rely heavily on anecdotal evidence (Hutchins et al., 2024). Within the medical model, gestalts are often discouraged, potentially leading to masking. This paper advocates for neurodiversity-affirming, individualized, and EBP-aligned approaches to support autistic language development.
Background
In 1977, Ann Peters identified children who acquire language in larger “chunks” or “gestalts” rather than individual words. These children learned and used full phrases from their environment. Building on this, Barry Prizant extended this concept to autistic children, highlighting how many use delayed echolalia—defined as the “repetition of utterances produced by others”—as meaningful communication.
In the 1980s, Prizant’s research formalized gestalt language processing (GLP) as a natural language-learning pathway for many autistic people. According to this model, autistic people often begin their language journey through echolalia, eventually breaking down these gestalts into smaller parts, ultimately supporting self-generated speech. Marge Blanc later introduced the Natural Language Acquisition (NLA) framework, outlining specific developmental stages for GLPs and proposing targeted intervention strategies (Blanc & Lyon, 2012; Blanc, Blackwell, & Elias, 2023).
Both academic and anecdotal sources affirm the communicative validity of echolalia. Prizant and Rydell (1984) highlighted its communicative functions, while recent research by Xie (2022) emphasized its intentional use. Anecdotal accounts from autistic people and caregivers describe echolalia as an essential form of expression and connection, reinforcing that what is often labeled “disordered” may be purposeful when viewed as a “difference”.
Evidence-Based Practice Considerations
EBP consists of three components: clinical expertise, best available external evidence, and client/caregiver perspectives (ASHA, n.d.). Quality care must account for the needs, preferences, and lived experiences of autistic people and their families.
GLP-informed strategies have encountered skepticism. Critics note these approaches lack extensive empirical validation and are predominantly supported by clinical experience rather than randomized controlled trials (Hutchins et al., 2024). While empirical research confirming NLA developmental stages and long-term efficacy is needed, it’s essential to recognize how autistic insights have reshaped scientific understanding.
Anecdotal, autistic-supported challenges to clinical assumptions have been validated when tested. Research shows the effectiveness of autistic-to-autistic communication (Crompton et al., 2020) and rapport (Foster et al., 2025), challenging assumptions that autistic communication is inherently deficient. Dismissing GLP and NLA outright due to lack of empirical testing may overlook transformative insights—especially when these approaches align with autistic lived experiences.
Medical Model vs. Neurodiversity-Affirming Approach
The medical model tends to pathologize echolalia and scripting, targeting them for reduction or elimination while emphasizing single-word utterances. Research shows such interventions may be ineffective and harmful. Attempts to extinguish echolalia often fail to increase communicative speech and may contribute to masking—efforts by autistic people to hide natural communication styles to conform to neurotypical expectations (Dinello & Gladfelter, 2025). These behaviors link to increased anxiety, depression, and identity challenges (Alaghband-Rad, Hajikarim-Hamedani, & Motamed, 2023).
Affirming GLP as legitimate aligns with a neurodiversity-affirming approach, recognizing echolalia and scripting as steppingstones rather than obstacles. Building on existing strengths makes intervention more effective and respectful.
Conclusion
This presentation supports integrating GLP-supportive approaches into clinical practice based on clinical expertise, internal client evidence, and client/caregiver perspectives. It highlights insights from practitioners working with GLPs who use AAC, qualitative evidence from autistic people, and initial research supporting GLP as a viable language acquisition route.
We propose a flexible, individualized approach for AAC users who are GLPs—honoring the EBP model in its entirety. While empirical validation is crucial, it had not yet been conducted for GLP approaches. Clinical decision-making must value lived experience and understanding of communication needs outside neurotypical norms. Supporting gestalt language processors requires openness to new frameworks and commitment to ethical, culturally responsive, and person-centered care. Empirical research is needed to validate specific interventions to support GLPs who use AAC.
